Connection

Yuval Naot to Antibodies, Monoclonal

Back to Details
This is a "connection" page, showing publications Yuval Naot has written about Antibodies, Monoclonal.
Yuval Naot
Connection Strength
0.017
Antibodies, Monoclonal
  1. Paclitaxel/carboplatin plus bevacizumab/erlotinib in the first-line treatment of patients with carcinoma of unknown primary site. Oncologist. 2009 Dec; 14(12):1189-97.
    View in: PubMed
    Score: 0.017
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.